Inventor · disambiguated record
Joseph L. Kim
Also filed as: KIM JOSEPH · KIM JOSEPH L
63 granted patents·31 pending applications·1,203 citations·filing 1995–2024
99Inventor score
Top patents by PatentIndex Score
94 records- 0198US10030005B2Inhibitors of RETBLUEPRINT MEDICINES CORP·Filed 2016·Granted Jul 24, 2018·38 cites·30 claims
- 0298US7282504B2Kinase inhibitorsAMGEN INC·Filed 2005·Granted Oct 16, 2007·90 cites·11 claims
- 0397US11279688B2Inhibitors of RETBLUEPRINT MEDICINES CORP·Filed 2020·Granted Mar 22, 2022·5 cites·2 claims
- 0497US9994575B2Compositions useful for treating disorders related to kitBLUEPRINT MEDICINES CORP·Filed 2015·Granted Jun 12, 2018·32 cites·20 claims
- 0597US9944651B2Compositions useful for treating disorders related to kitBLUEPRINT MEDICINES CORP·Filed 2017·Granted Apr 17, 2018·33 cites·24 claims
- 0697US9884861B2Compositions useful for treating disorders related to kitBLUEPRINT MEDICINES CORP·Filed 2016·Granted Feb 6, 2018·32 cites·7 claims
- 0797US9340514B2Inhibitors of the fibroblast growth factor receptorBLUEPRINT MEDICINES CORP·Filed 2015·Granted May 17, 2016·43 cites·11 claims
- 0897US9200002B2Compositions useful for treating disorders related to KITHODOUS BRIAN L·Filed 2014·Granted Dec 1, 2015·49 cites·6 claims
- 0997US8802697B2Inhibitors of the fibroblast growth factor receptorBIFULCO JR NEIL·Filed 2013·Granted Aug 12, 2014·91 cites·9 claims
- 1096US11827642B2Compositions useful for treating disorders related to KITBLUEPRINT MEDICINES CORP·Filed 2022·Granted Nov 28, 2023·2 cites·6 claims
- 1196US9994552B2Compositions useful for treating disorders related to kitBLUEPRINT MEDICINES CORP·Filed 2016·Granted Jun 12, 2018·31 cites·10 claims
- 1296US9126951B2Inhibitors of the fibroblast growth factor receptorBIFULCO JR NEIL·Filed 2014·Granted Sep 8, 2015·47 cites·41 claims
- 1395US10584114B2Inhibitors of RETBLUEPRINT MEDICINES CORP·Filed 2018·Granted Mar 10, 2020·13 cites·3 claims
- 1495US10183928B2Inhibitors of RETBLUEPRINT MEDICINES CORP·Filed 2017·Granted Jan 22, 2019·13 cites·47 claims
- 1595US9334263B2Compositions useful for treating disorders related to kitHODOUS BRIAN L·Filed 2014·Granted May 10, 2016·41 cites·21 claims
- 1695US6878714B2Substituted alkylamine derivatives and methods of useAMGEN INC·Filed 2002·Granted Apr 12, 2005·85 cites·39 claims
- 1794US11534441B2MAP4K1 inhibitorsBLUEPRINT MEDICINES CORP·Filed 2021·Granted Dec 27, 2022·3 cites·25 claims
- 1894US10378063B2RAF1 fusionsBLUEPRINT MEDICINES CORP·Filed 2015·Granted Aug 13, 2019·8 cites·6 claims
- 1994US10202365B22-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitorsBLUEPRINT MEDICINES CORP·Filed 2016·Granted Feb 12, 2019·20 cites·15 claims
- 2093US11718602B2EGFR inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Granted Aug 8, 2023·2 cites·8 claims
- 2193US10233186B2Inhibitors of activin receptor-like kinaseBLUEPRINT MEDICINES CORP·Filed 2017·Granted Mar 19, 2019·16 cites·56 claims
- 2293US9499522B2Compositions useful for treating disorders related to kitDIPIETRO LUCIAN V·Filed 2014·Granted Nov 22, 2016·40 cites·27 claims
- 2392US10774070B22-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitorsBLUEPRINT MEDICINES CORP·Filed 2018·Granted Sep 15, 2020·6 cites·14 claims
- 2492US6995162B2Substituted alkylamine derivatives and methods of useAMGEN INC·Filed 2002·Granted Feb 7, 2006·48 cites·26 claims
- 2591US11970498B2CDK2 inhibitorsBLUEPRINT MEDICINES CORP·Filed 2023·Granted Apr 30, 2024·1 cites·26 claims
- 2691US7880000B2Protein kinase modulators and method of useAMGEN INC·Filed 2005·Granted Feb 1, 2011·21 cites·19 claims
- 2791US7435823B2Compounds and methods of useAMGEN INC·Filed 2005·Granted Oct 14, 2008·19 cites·23 claims
- 2890US12042495B2MAP4K1 inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Granted Jul 23, 2024·1 cites·18 claims
- 2990US7514564B2Substituted amine derivatives and methods of useAMGEN INC·Filed 2006·Granted Apr 7, 2009·16 cites·15 claims
- 3089US11932648B2CDK2 inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Granted Mar 19, 2024·1 cites·18 claims
- 3189US7531553B2Heterocyclic compounds and methods of useAMGEN INC·Filed 2004·Granted May 12, 2009·44 cites·15 claims
- 3289US7074789B2Kinase inhibitorsAMGEN INC·Filed 2003·Granted Jul 11, 2006·25 cites·7 claims
- 3387US7105682B2Substituted amine derivatives and methods of useAMGEN INC·Filed 2002·Granted Sep 12, 2006·29 cites·17 claims
- 3487US2024317757A1Compositions useful for treating disorders related to kitBLUEPRINT MEDICINES CORP·Filed 2023·Application pending·0 cites
- 3586US8642624B2Substituted alkylamine derivatives and methods of useCHEN GUOQING·Filed 2011·Granted Feb 4, 2014·11 cites·3 claims
- 3686US8476434B2Protein kinase modulators and method of useGEUNS-MEYER STEPHANIE D·Filed 2010·Granted Jul 2, 2013·17 cites·9 claims
- 3785US7101868B2Substituted arylamine derivatives and methods of useAMGEN INC·Filed 2004·Granted Sep 5, 2006·20 cites·36 claims
- 3885US2024417386A1Inhibitors of retRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3984US5978740AMolecules comprising a calcineurin-like binding pocket and encoded data storage medium capable of graphically displaying themVERTEX PHARMA·Filed 1995·Granted Nov 2, 1999·45 cites·6 claims
- 4083US11634422B2Inhibitors of activin receptor-like kinaseBLUEPRINT MEDICINES CORP·Filed 2020·Granted Apr 25, 2023·1 cites·30 claims
- 4183US8017601B2Bis-aryl kinase inhibitors and methodAMGEN INC·Filed 2006·Granted Sep 13, 2011·7 cites·18 claims
- 4280US6183121B1Hepatitis C virus helicase crystals and coordinates that define helicase binding pocketsVERTEX PHARMA·Filed 1998·Granted Feb 6, 2001·61 cites·17 claims
- 4380US2025289801A1Egfr inhibitorsBLUEPRINT MEDICINES CORP·Filed 2024·Application pending·0 cites
- 4477US12448379B2Wild type kit inhibitorsBLUEPRINT MEDICINES CORP·Filed 2024·Granted Oct 21, 2025·0 cites·33 claims
- 4577US6864255B2Substituted triazinyl amide derivatives and methods of useAMGEN INC·Filed 2002·Granted Mar 8, 2005·10 cites·14 claims
- 4677US2022315560A1Inhibitors of retBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 4774US6881737B2Substituted triazinyl acrylamide derivatives and methods of useAMGEN INC·Filed 2002·Granted Apr 19, 2005·8 cites·7 claims
- 4874US2022213553A1Prkc fusionsBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 4974US2021284645A1Compositions useful for treating disorders related to kitBLUEPRINT MEDICINES CORP·Filed 2020·Application pending·0 cites
- 5073US10370379B2Compounds and compositions useful for treating disorders related to NTRKBLUEPRINT MEDICINES CORP·Filed 2016·Granted Aug 6, 2019·1 cites·12 claims
Showing the top 50 of 94 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Joseph L. Kim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →